Biomimetic chromatographic analysis of selenium species: application for the estimation of their pharmacokinetic properties.
The retention behavior of selenites, selenates, seleno-DL-methionine, selenocystine, selenocystamine, selenourea, dimethyl selenide, and dimethyl diselenide was investigated by means of biomimetic liquid chromatography. For this purpose, two immobilized artificial membrane (IAM) columns, namely, IAM.PC.DD2 and IAM.PC.MG, and two immobilized plasma protein columns, human serum albumin (HSA) and alpha(1)-acid glycoprotein (AGP) columns, were employed using different mobile phase conditions in respect to pH and buffer composition. In general, satisfactory interrelations between retention factors obtained with the two IAM stationary phases and HSA/AGP columns were obtained. Large differences were observed between biomimetic retention factors and octanol-water logD values, since the latter fail to describe electrostatic interactions. In contrast, despite the column diversity, the net retention outcome on all four biomimetic columns was quite similar, especially in the presence of phosphate-buffered saline, which by its effective shielding alleviates the differences between the stationary phases. Of the two IAM columns, IAM.PC.DD2 showed better performance when compared with HSA and AGP columns as well as to octanol-water partitioning. Biomimetic chromatographic indices were further used to estimate the percentage of human oral absorption and plasma protein binding of the eight selenium species investigated, according to equations previously reported in the literature. The estimated values of human oral absorption imply moderate absorption only for dimethyl diselenide, which also may exhibit considerable plasma protein binding. Moderate affinity for plasma proteins should also be expected for dimethyl selenide and selenocystamine.
Tsopelas
Fotios
F
Laboratory of Inorganic and Analytical Chemistry, School of Chemical Engineering, National Technical University of Athens, Iroon Polytechniou 9, 157 73 Athens, Greece. ftsop@central.ntua.gr
Tsantili-Kakoulidou
Anna
A
Ochsenkühn-Petropoulou
Maria
M
D000042:Absorption; D032701:Biomimetics / Q000379:methods*; D002853:Chromatography, Liquid / Q000379:methods*; D006801:Humans; D008567:Membranes, Artificial; D008954:Models, Biological; D016566:Organoselenium Compounds / Q000032:analysis / Q000493:pharmacokinetics*; D009961:Orosomucoid / Q000737:chemistry; D064586:Selenic Acid; D012643:Selenium / Q000032:analysis / Q000493:pharmacokinetics*; D018036:Selenium Compounds / Q000032:analysis / Q000493:pharmacokinetics; D012709:Serum Albumin / Q000737:chemistry; D018038:Sodium Selenite / Q000032:analysis / Q000493:pharmacokinetics
D008567:Membranes, Artificial; D016566:Organoselenium Compounds; D009961:Orosomucoid; D018036:Selenium Compounds; D012709:Serum Albumin; D012643:Selenium; D018038:Sodium Selenite; D064586:Selenic Acid